Balance Sheet

Assets

-30%

-19%

10Y

Currency: VND

	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	6 297	12 725	6 392	28 232	47 676	66 987	89 010	122 037	106 091	95 854	169 940	169 724	115 026	29 430	37 454	13 252	60 084	40 564
Cash	6 297	12 725	6 392	4 732	5 176	6 987	3 010	3 037	11 091	4 854	4 140	14 224	13 026	29 430	23 454	13 252	14 084	40 564
Cash Equivalents	0	0	0	23 500	42 500	60 000	86 000	119 000	95 000	91 000	165 800	155 500	102 000	0	14 000	0	46 000	0
Short-Term Investments	0	0	19 000	0	0	0	0	0	22 000	47 500	0	0	111 500	242 131	256 100	249 000	141 000	500
Total Receivables	18 159	19 074	19 160	22 425	24 827	31 213	35 032	34 097	34 125	34 974	39 808	40 598	35 294	41 335	38 487	42 915	44 266	39 243
Accounts Receivables	17 928	19 037	18 711	22 000	24 606	30 734	34 702	32 661	33 129	32 868	38 616	39 256	34 034	39 175	35 254	39 310	41 222	33 666
Other Receivables	231	37	449	425	221	479	330	1 436	996	2 107	1 193	1 342	1 260	2 159	3 233	3 605	3 044	5 576
Inventory	36 556	34 283	39 207	60 911	60 900	70 813	64 874	56 942	73 723	90 196	89 057	93 282	89 414	71 379	104 546	67 244	71 119	103 930
Other Current Assets	2 909	1 976	3 085	2 121	1 924	6 893	7 379	8 291	13 960	8 771	3 948	24 788	4 700	4 768	4 555	6 660	18 966	35 339
Total Current Assets	63 921	68 059	86 844	113 689	135 327	175 906	196 296	221 368	249 899	277 295	302 753	328 392	355 934	389 042	441 141	379 071	335 436	219 576
PP&E Net	39 014	32 140	33 745	33 885	30 122	29 999	34 725	35 318	41 414	48 674	45 695	50 182	65 179	53 900	45 890	39 704	32 127	93 635
PP&E Gross	39 014	32 140	33 745	33 885	30 122	29 999	34 725	35 318	41 414	48 674	45 695	50 182	65 179	53 900	45 890	39 704	32 127	93 635
Accumulated Depreciation	56 204	67 868	72 427	78 842	85 478	86 946	93 169	100 465	109 238	117 550	126 703	136 784	149 416	160 098	169 545	180 578	191 782	197 964
Intangible Assets	346	3 088	3 782	3 495	3 259	3 023	2 846	2 575	2 607	3 991	3 949	3 454	3 165	2 991	2 731	2 443	2 214	1 998
Long-Term Investments	75	75	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	0	1 632	0	592	0	0	436	2 015	3 071	2 486	2 118	2 081	4 774	5 560	4 362	5 157	6 062	30 216
Total Assets	103 357 N/A	104 995 +2%	124 371 +18%	151 661 +22%	168 708 +11%	208 928 +24%	234 303 +12%	261 275 +12%	296 991 +14%	332 446 +12%	354 515 +7%	384 110 +8%	429 053 +12%	451 494 +5%	494 124 +9%	426 375 -14%	375 839 -12%	345 424 -8%
Liabilities
Accounts Payable	169	1 548	4 697	5 620	6 510	8 299	4 270	6 524	9 981	12 853	8 321	8 426	12 575	8 378	15 668	12 730	16 250	28 535
Accrued Liabilities	3 344	6 658	9 243	18 132	24 377	28 366	35 690	35 532	36 569	37 617	32 253	28 604	40 900	37 790	35 498	44 388	44 114	45 726
Short-Term Debt	13 289	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	181
Other Current Liabilities	6 840	7 191	5 200	8 973	10 752	13 640	12 349	13 008	12 108	13 221	13 796	14 985	11 404	16 449	15 177	26 060	25 863	30 127
Total Current Liabilities	23 642	15 398	19 140	32 725	41 639	50 305	52 309	55 065	58 658	63 692	54 370	52 015	64 879	62 617	66 342	83 178	86 227	104 569
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	420	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Liabilities	23 642 N/A	15 818 -33%	19 140 +21%	32 725 +71%	41 639 +27%	50 305 +21%	52 309 +4%	55 065 +5%	58 658 +7%	63 692 +9%	54 370 -15%	52 015 -4%	64 879 +25%	62 617 -3%	66 342 +6%	83 178 +25%	86 227 +4%	104 569 +21%
Equity
Common Stock	64 816	64 816	64 816	64 816	64 816	93 326	93 326	93 326	93 326	93 326	93 326	93 326	93 326	93 326	93 326	93 326	93 326	93 326
Retained Earnings	10 812	11 385	20 822	26 747	25 836	32 753	37 909	39 024	46 882	45 730	46 420	47 006	47 155	39 785	53 814	53 923	102 063	53 306
Additional Paid In Capital	913	913	913	913	973	973	973	973	973	973	973	973	973	973	973	973	973	973
Treasury Stock	93	93	93	93	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Equity	3 266	12 156	18 773	26 553	35 444	31 572	49 786	72 888	97 153	128 726	159 426	190 791	222 720	254 793	279 669	194 975	93 250	93 250
Total Equity	79 715 N/A	89 177 +12%	105 232 +18%	118 936 +13%	127 069 +7%	158 623 +25%	181 994 +15%	206 210 +13%	238 334 +16%	268 754 +13%	300 145 +12%	332 096 +11%	364 173 +10%	388 877 +7%	427 782 +10%	343 197 -20%	289 612 -16%	240 855 -17%
Total Liabilities & Equity	103 357 N/A	104 995 +2%	124 371 +18%	151 661 +22%	168 708 +11%	208 928 +24%	234 303 +12%	261 275 +12%	296 991 +14%	332 446 +12%	354 515 +7%	384 110 +8%	429 053 +12%	451 494 +5%	494 124 +9%	426 375 -14%	375 839 -12%	345 424 -8%
Shares Outstanding
Common Shares Outstanding	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9	9

Income Statement Balance Sheet Cash Flow Statement

Pharmedic Pharmaceutical Medicinal JSC
VN:PMC

Balance Sheet

Balance Sheet Decomposition
Pharmedic Pharmaceutical Medicinal JSC

Balance Sheet
Pharmedic Pharmaceutical Medicinal JSC

See Also

Company

Help

Tools

Stocks

Pharmedic Pharmaceutical Medicinal JSC VN:PMC

Balance Sheet

Balance Sheet Decomposition Pharmedic Pharmaceutical Medicinal JSC

Balance Sheet Pharmedic Pharmaceutical Medicinal JSC

See Also

Company

Help

Tools

Stocks

Pharmedic Pharmaceutical Medicinal JSC
VN:PMC

Balance Sheet Decomposition
Pharmedic Pharmaceutical Medicinal JSC

Balance Sheet
Pharmedic Pharmaceutical Medicinal JSC